Reduced GSK-3β mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients

Author： Kozlovsky N.   Shanon-Weickert C.   Tomaskovic-Crook E.   Kleinman J. E.   Belmaker R. H.   Agam G.  

Publisher： Springer Publishing Company

ISSN： 0300-9564

Source： Journal of Neural Transmission, Vol.111, Iss.12, 2004-12, pp. : 1583-1592

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Reduced GAP-43 mRNA in Dorsolateral Prefrontal Cortex of Patients with Schizophrenia

By Weickert Cynthia Shannon   Webster Maree J.  

Cerebral Cortex, Vol. 11, Iss. 2, 2001-02 ,pp. : 136-147

Oxford University Press

Access to resources Recommend Favorite

Alterations in Somatostatin mRNA Expression in the Dorsolateral Prefrontal Cortex of Subjects with Schizophrenia or Schizoaffective Disorder

By Morris Harvey M.   Hashimoto Takanori   Lewis David A.  

Cerebral Cortex, Vol. 18, Iss. 7, 2008-07 ,pp. : 1575-1587

Oxford University Press

Access to resources Recommend Favorite

-Secretase (BACE) and GSK-3 mRNA levels in Alzheimer's disease

By Preece P.   Virley D.J.   Costandi M.   Coombes R.   Moss S.J.   Mudge A.W.   Jazin E.   Cairns N.J.  

Molecular Brain Research, Vol. 116, Iss. 1, 2003-08 ,pp. : 155-158

Elsevier

Access to resources Recommend Favorite

[ 3 H]RX 821002 in human dorsolateral prefrontal cortex: no changes in postmortem tissue from subjects with schizophrenia

By Dean B.  

Psychiatry Research, Vol. 119, Iss. 1, 2003-07 ,pp. : 25-31

Elsevier

Access to resources Recommend Favorite

Evidence for gamma inhibition deficits in the dorsolateral prefrontal cortex of patients with schizophrenia

By Farzan Faranak  

Brain, Vol. 133, Iss. 5, 2010-05 ,pp. : 1505-1514

Oxford University Press

Access to resources Recommend Favorite